Robert W. Duggan - 06 Mar 2023 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Executive Officer, Director
Signature
/s/ Robert W. Duggan
Issuer symbol
SMMT
Transactions as of
06 Mar 2023
Net transactions value
+$395,314,374
Form type
4
Filing time
08 Mar 2023, 15:12:01 UTC
Previous filing
08 Dec 2022
Next filing
10 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Purchase $395,314,374 +376,489,880 +214% $1.05 552,354,161 06 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.